US 11464841
TERT immunogenic compositions and methods of treatment using the same
granted A61KA61K2039/53A61K2039/55538
Quick answer
US patent 11464841 (TERT immunogenic compositions and methods of treatment using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/53, A61K2039/55538, A61K2039/572, A61K2039/575